Increased Oversight of Medicare Advantage Providers by U.S. Senators
U.S. senators have increased oversight on major Medicare Advantage providers, including UnitedHealthcare, focusing on their use of artificial intelligence in prior authorization policies that impact post-hospital rehabilitation care. Senators Richard Blumenthal and Josh Hawley have requested detailed information from the CEOs of UnitedHealthcare, Humana, and CVS Health regarding their methods for processing coverage decisions.
A recent report from the Office of Inspector General at the U.S. Department of Health and Human Services revealed that these insurers denied requests for post-hospital care more frequently—between 51% and 80%—compared to other providers. Medicare Advantage, an alternative to traditional Medicare managed by private companies, faces criticism for its approval processes. In a joint letter, the senators criticized the lack of comprehensive reporting by these insurers, arguing it obscures the extent of care denials due to prior authorization practices.
AI and Legal Challenges
The scrutiny intensifies following an unresolved 2023 lawsuit in Minnesota, alleging UnitedHealthcare's improper utilization of AI to boost profitability by restricting care access. The senators referenced an October 2024 subcommittee report indicating higher denial rates for post-acute care authorizations than other healthcare services.
UnitedHealthcare responded by asserting that federal reports offer an incomplete view, noting that most post-acute care requests are eventually approved. The insurer clarified they do not deploy AI in clinical denials and mentioned a process for case reviews when new information arises.
Impact on Healthcare Providers
A separate analysis highlighted UnitedHealth Group's subsidiary, naviHealth, where initial denials for skilled nursing facilities were frequently overturned upon appeal. This finding suggests that essential care might initially be withheld. UnitedHealthcare maintains that their evaluation procedures adhere to evidence-based criteria and federal standards, aiming to deliver care that best suits patients' clinical needs.
The tension between insurers and healthcare providers over AI-driven prior authorization has escalated. Health systems like Fairview Health Services have opted to discontinue appointments for UnitedHealthcare Medicare Advantage members due to authorization delays. The debate also touches on cost management, given the significant expenses associated with post-hospitalization rehabilitation, which can vary widely.
Finally, a related lawsuit claims UnitedHealthcare terminated coverage using naviHealth’s AI tools, forcing patients to consider paying out-of-pocket or foregoing necessary rehabilitation care. These ongoing legal and regulatory challenges may influence future operational practices within the Medicare Advantage sector.